Mode
Text Size
Log in / Sign up

New review shows prostate cancer screening might save lives but also finds more diagnoses

Share
New review shows prostate cancer screening might save lives but also finds more diagnoses
Photo by National Institute of Allergy and Infectious Diseases / Unsplash

This big review looked at many studies involving men between forty-five and eighty years old. Doctors in Europe and North America tested these men using blood checks for prostate specific antigen or other tools. They compared this to men who did not get these special checks. The goal was to see if finding cancer early helps people live longer or if it causes more harm.

The main finding is that checking for cancer likely helps men avoid dying from prostate cancer. If about sixteen men out of one thousand would die from this disease without a check, the review suggests two fewer deaths per one thousand men who were screened. This means the test works to save lives from this specific illness. The evidence for this benefit is considered fairly strong by the experts.

However, finding cancer early does not always mean living longer. The study looked at deaths from all causes, not just prostate cancer. The results here are not very clear. It is possible that screening saves some lives, but it is also possible that it does not change the total number of deaths from any cause. The numbers are very close to zero difference.

Another important point is that screening finds more cases of cancer. Many more men are told they have cancer when they get the blood test. Most of these extra cases are found early, before they spread. This is good because early cancer is easier to treat. But it also means more men might get worried or have unnecessary tests.

The review also looked at serious side effects like problems from biopsies or treatments. The data suggests there is little difference in these bad events between men who were screened and those who were not. The study did not have enough information to say for sure about newer tests like MRI scans. More research is needed to know if these new tools are safe and helpful.

In short, screening can lower the risk of dying from prostate cancer. It might also lower the risk of dying from any cause, but we are not sure yet. The main trade-off is finding more cancers, which are usually found early. Men should talk to their doctors about the pros and cons before deciding to be screened.

What this means for you:
Screening likely lowers death from prostate cancer but finds more cases, with unclear effects on total deaths.
Share
More on Prostate Cancer